• UK vaccine clinical trial outsourcing expansion continues europeanpharmaceuticalreview
    May 05, 2020
    An outsourcing company has announced that Phase II, III and IV clinical trials of vaccines will continue at a growing number of sites, assessing the safety of each in light of COVID-19.
PharmaSources Customer Service